Thiolated arsenicals in arsenic metabolism: Occurrence, formation, and biological implications

Journal of Environmental Sciences (China)

Volumn 49, Issue , 2016, Pages 59-73

  Sun, Yuzhen ^a   Liu, Guangliang ^a   Cai, Yong ^a,b  

^a JIANGHAN UNIVERSITY   (China)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Arsenic; Formation pathways; Occurrence; Thioarsenicals; Toxicity

Indexed keywords

ARSENIC; BIOLOGICAL SYSTEMS; DISEASES; HEALTH RISKS; METABOLISM; METABOLITES; PEPTIDES; PHYSIOLOGY; TOXICITY;

BIOLOGICAL IMPLICATIONS; CANCER INDUCTION; DIMETHYLARSINIC ACIDS; FORMATION PATHWAYS; OCCURRENCE; THERAPEUTIC EFFECTS; THIOARSENICALS; TOXIC POLLUTANTS;

ARSENIC COMPOUNDS;

ARSENIC; DISEASE TREATMENT; METABOLISM; TOXICITY;

ARSENIC; ARSENIC TRIOXIDE; ARSENOUS ACID DERIVATIVE; CACODYLIC ACID; DIMETHYLDITHIOARSINIC ACID; DIMETHYLMONOTHIOARSINIC ACID; MONOMETHYLMONOTHIOARSONIC ACID; ORGANOARSENIC DERIVATIVE;

ANALOGS AND DERIVATIVES; HUMAN; METABOLISM;

ARSENIC; ARSENICALS; ARSENITES; CACODYLIC ACID; HUMANS;

EID: 85006355624     PISSN: 10010742     EISSN: 18787320     Source Type: Journal    
DOI: 10.1016/j.jes.2016.08.016     Document Type: Review

References (147)

1. Adair, B.M., Moore, T., Conklin, S.D., Creed, J.T., Wolf, D.C., Thomas, D.J., Tissue distribution and urinary excretion of dimethylated arsenic and its metabolites in dimethylarsinic acid- or arsenate-treated rats. Toxicol. Appl. Pharmacol. 222 (2007), 235–242.
2. Antonio, T., Chopoa, A.K., Cullen, W.R., Dolphin, D., A model for the biological methylation of arsenic. J. Inorg. Nucl. Chem. 41 (1979), 1220–1221.
3. Apostolia Maria, T., Camacho, L.H., Srdan, V., Chaan, N., Hong, D.S., Uehara, C.K., et al. A phase I clinical trial of darinaparsin in patients with refractory solid tumors. Clin. Cancer Res. 15 (2009), 4769–4776.
4. Bartel, M., Ebert, F., Leffers, L., Karst, U., Schwerdtle, T., Toxicological characterization of the inorganic and organic arsenic metabolite thio-DMA in cultured human lung cells. J. Toxicol., 2011, 2011.
5. Bogdan, G.M., Sampayo-Reyes, A., Vasken Aposhian, H., Arsenic binding proteins of mammalian systems: I. Isolation of three arsenite-binding proteins of rabbit liver. Toxicology 93 (1994), 175–193.
6. Bouteille, B., Oukem, O., Bisser, S., Dumas, M., Treatment perspectives for human African trypanosomiasis. Fundam. Clin. Pharmacol. 17 (2003), 171–181.
7. Bu, N., Wang, H.Y., Hao, W.H., Liu, X., Xu, S., Wu, B., et al. Generation of thioarsenicals is dependent on the enterohepatic circulation in rats. Metallomics 3 (2011), 1064–1073.
8. Burton, E.D., Johnston, S.G., Planer-Friedrich, B., Coupling of arsenic mobility to sulfur transformations during microbial sulfate reduction in the presence and absence of humic acid. Chem. Geol. 343 (2013), 12–24.
9. Carter, D.E., Aposhian, H.V., Gandolfi, A.J., The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: a toxicochemical review. Toxicol. Appl. Pharmacol. 193 (2003), 309–334.
10. Challenger, F., Biological methylation. Chem. Rev. 36 (1945), 315–361.
11. Chen, Z., Zhao, W.-L., Shen, Z.-X., Li, J.-M., Chen, S.-J., Zhu, J., et al. Arsenic Trioxide and Acute Promyelocytic Leukemia: Clinical and Biological, Acute Promyelocytic Leukemia. 2007, Springer, 129–144.
12. Chen, B., Cao, F., Yuan, C., Lu, X., Shen, S., Zhou, J., et al. Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment. Anal. Bioanal. Chem. 405 (2013), 1903–1911.
13. Chen, B., Lu, X., Shen, S., Arnold, L.L., Cohen, S.M., Le, X.C., Arsenic speciation in the blood of arsenite-treated F344 rats. Chem. Res. Toxicol. 26 (2013), 952–962.
14. Chen, B., Liu, Q., Popowich, A., Shen, S., Yan, X., Zhang, Q., et al. Therapeutic and analytical applications of arsenic binding to proteins. Metallomics 7 (2015), 39–55.
15. Cohen, S.M., Chowdhury, A., Arnold, L.L., Inorganic arsenic: a non-genotoxic carcinogen. J. Environ. Sci. 49 (2016), 28–37.
16. Conklin, S.D., Creed, P.A., Creed, J.T., Detection and quantification of a thio-arsenosugar in marine molluscs by IC–ICP-MS with an emphasis on the interaction of arsenosugars with sulfide as a function of pH. J. Anal. At. Spectrom. 21 (2006), 869–875.
17. Conklin, S.D., Fricke, M.W., Creed, P.A., Creed, J.T., Investigation of the pH effects on the formation of methylated thio-arsenicals, and the effects of pH and temperature on their stability. J. Anal. At. Spectrom. 23 (2008), 711–716.
18. Couture, R.-M., Wallschläger, D., Rose, J., Van Cappellen, P., Arsenic binding to organic and inorganic sulfur species during microbial sulfate reduction: a sediment flow-through reactor experiment. Environ. Chem. 10 (2013), 285–294.
19. Cullen, W.R., Chemical mechanism of arsenic biomethylation. Chem. Res. Toxicol. 27 (2014), 457–461.
20. Dan, D., Tallman, M.S., Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies. J. Clin. Oncol. 23 (2005), 2396–2410.
21. Del Razo, L.M., Styblo, M., Cullen, W.R., Thomas, D.J., Determination of trivalent methylated arsenicals in biological matrices. Toxicol. Appl. Pharmacol. 174 (2001), 282–293.
22. Deplancke, B., Hristova, K., Oakley, H., McCracken, V., Aminov, R., Mackie, R., et al. Molecular ecological analysis of the succession and diversity of sulfate-reducing bacteria in the mouse gastrointestinal tract. Appl. Environ. Microbiol. 66 (2000), 2166–2174.
23. Devesa, V., Del Razo, L.M., Adair, B., Drobná, Z., Waters, S.B., Hughes, M.F., et al. Comprehensive analysis of arsenic metabolites by pH-specific hydride generation atomic absorption spectrometry. J. Anal. At. Spectrom. 19 (2004), 1460–1467.
24. Diaz-Bone, R.A., Hollmann, M., Wuerfel, O., Pieper, D., Analysis of volatile arsenic compounds formed by intestinal microorganisms: rapid identification of new metabolic products by use of simultaneous EI–MS and ICP-MS detection after gas chromatographic separation. J. Anal. At. Spectrom. 24 (2009), 808–814.
25. Drobna, Z., Naranmandura, H., Kubachka, K.M., Edwards, B.C., Herbin-Davis, K., Styblo, M., et al. Disruption of the arsenic (+ 3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate. Chem. Res. Toxicol. 22 (2009), 1713–1720.
26. Ebert, F., Leffers, L., Weber, T., Berndt, S., Mangerich, A., Beneke, S., et al. Toxicological properties of the thiolated inorganic arsenic and arsenosugar metabolite thio-dimethylarsinic acid in human bladder cells. J. Trace Elem. Med. Biol. 28 (2014), 138–146.
27. Fisher, J.C., Wallschläger, D., Planer-Friedrich, B., Hollibaugh, J.T., A new role for sulfur in arsenic cycling. Environ. Sci. Technol. 42 (2008), 81–85.
28. Foster, S., Maher, W., Arsenobetaine and thio-arsenic species in marine macroalgae and herbivorous animals: accumulated through trophic transfer or produced in situ?. J. Environ. Sci. 49 (2016), 131–139.
29. Fricke, M., Zeller, M., Cullen, W., Witkowski, M., Creed, J., Dimethylthioarsinic anhydride: a standard for arsenic speciation. Anal. Chim. Acta 583 (2007), 78–83.
30. Garnier, N., Petruccelli, L.A., Molina, M.F., Kourelis, M., Kwan, S., Diaz, Z., et al. The novel arsenical darinaparsin circumvents BRG1-dependent, HO-1-mediated cytoprotection in leukemic cells. Leukemia 27 (2013), 2220–2228.
31. Geng, W., Komine, R., Ohta, T., Nakajima, T., Takanashi, H., Ohki, A., Arsenic speciation in marine product samples: comparison of extraction–HPLC method and digestion–cryogenic trap method. Talanta 79 (2009), 369–375.
32. Ghosh, A., Transition metal spin state energetics and noninnocent systems: challenges for DFT in the bioinorganic arena. J. Biol. Inorg. Chem. 11 (2006), 712–724.
33. Gibaud, S., Jaouen, G., Arsenic-based Drugs: From Fowler's Solution to Modern Anticancer Chemotherapy, Medicinal Organometallic Chemistry. 2010, Springer, 1–20.
34. Gong, Z., Lu, X., Cullen, W.R., Chris Le, X., Unstable trivalent arsenic metabolites, monomethylarsonous acid and dimethylarsinous acid. J. Anal. At. Spectrom. 16 (2001), 1409–1413.
35. Hansen, H.R., Raab, A., Jaspars, M., Milne, B.F., Feldmann, J., Sulfur-containing arsenical mistaken for dimethylarsinous acid [DMA(III)] and identified as a natural metabolite in urine: major implications for studies on arsenic metabolism and toxicity. Chem. Res. Toxicol. 17 (2004), 1086–1091.
36. Hayakawa, T., Kobayashi, Y., Cui, X., Hirano, S., A new metabolic pathway of arsenite: arsenic–glutathione complexes are substrates for human arsenic methyltransferase cyt19. Arch. Toxicol. 79 (2005), 183–191.
37. He, Y., Guo, J., Density functional calculations of molecular structures of arsenic-binding β-domain of metallothioneins-2. Comput. Theor. Chem. 1058 (2015), 54–60.
38. Helle Rusz, H., Russell, P., Jane, T.O., Marcel, J., Jörg, F., 2-Dimethylarsinothioyl acetic acid identified in a biological sample: the first occurrence of a mammalian arsinothioyl metabolite. Angew. Chem. Int. Ed. 43 (2004), 337–340.
39. Hernández-Zavala, A., Matoušek, T., Drobná, Z., Paul, D.S., Walton, F., Adair, B.M., et al. Speciation analysis of arsenic in biological matrices by automated hydride generation–cryotrapping–atomic absorption spectrometry with multiple microflame quartz tube atomizer (multiatomizer). J. Anal. At. Spectrom. 23 (2008), 342–351.
40. Hippler, J., Zdrenka, R., Reichel, R.A.D., Weber, D.G., Rozynek, P., Johnen, G., et al. Intracellular, time-resolved speciation and quantification of arsenic compounds in human urothelial and hepatoma cells. J. Anal. At. Spectrom. 26 (2011), 2396–2403.
41. Hirano, S., Kobayashi, Y., Cui, X., Kanno, S., Hayakawa, T., Shraim, A., The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds. Toxicol. Appl. Pharmacol. 198 (2004), 458–467.
42. Hollibaugh, J.T., Carini, S., Gürleyük, H., Jellison, R., Joye, S.B., LeCleir, G., et al. Arsenic speciation in Mono Lake, California: response to seasonal stratification and anoxia. Geochim. Cosmochim. Acta 69 (2005), 1925–1937.
43. Hong, Y.-S., Song, K.-H., Chung, J.-Y., Health effects of chronic arsenic exposure. J. Prev. Med. Public Health 47 (2014), 245–252.
44. Jensen, K.P., Metal[sbnd]ligand bonds of second- and third-row d-block metals characterized by density functional theory. J. Phys. Chem. A 113 (2009), 10133–10141.
45. Jiang, H., Hu, B., Chen, B., Xia, L., Hollow fiber liquid phase microextraction combined with electrothermal atomic absorption spectrometry for the speciation of arsenic (III) and arsenic (V) in fresh waters and human hair extracts. Anal. Chim. Acta 634 (2009), 15–21.
46. Kala, S.V., Kala, G., Prater, C.I., Sartorelli, A.C., Lieberman, M.W., Formation and urinary excretion of arsenic triglutathione and methylarsenic diglutathione. Chem. Res. Toxicol. 17 (2004), 243–249.
47. Kösters, J., Diaz-Bone, R., Planer-Friedrich, B., Rothweiler, B., Hirner, A., Identification of organic arsenic, tin, antimony and tellurium compounds in environmental samples by GC–MS. J. Mol. Struct. 661 (2003), 347–356.
48. Kubachka, K.M., Kohan, M.C., Conklin, S.D., Herbin-Davis, K., Creed, J.T., Thomas, D.J., In vitro biotransformation of dimethylarsinic acid and trimethylarsine oxide by anaerobic microflora of mouse cecum analyzed by HPLC–ICP-MS and HPLC–ESI-MS. J. Anal. At. Spectrom. 24 (2009), 1062–1068.
49. Kubachka, K.M., Kohan, M.C., Herbin-Davis, K., Creed, J.T., Thomas, D.J., Exploring the in vitro formation of trimethylarsine sulfide from dimethylthioarsinic acid in anaerobic microflora of mouse cecum using HPLC–ICP-MS and HPLC–ESI-MS. Toxicol. Appl. Pharmacol. 239 (2009), 137–143.
50. Kurosawa, H., Shimoda, Y., Miura, M., Kato, K., Yamanaka, K., Hata, A., et al. A novel metabolic activation associated with glutathione in dimethylmonothioarsinic acid (DMMTAV)-induced toxicity obtained from in vitro reaction of DMMTAV with glutathione. J. Trace Elem. Med. Biol. 33 (2016), 87–94.
51. Le, X.C., Lu, X., Ma, M., Cullen, W.R., Aposhian, H.V., Zheng, B., Speciation of key arsenic metabolic intermediates in human urine. Anal. Chem. 72 (2000), 5172–5177.
52. Le, X.C., Ma, M., Cullen, W., Aposhian, H., Lu, X., Zheng, B., Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ. Health Perspect., 108, 2000, 1015.
53. Leffers, L., Unterberg, M., Bartel, M., Hoppe, C., Pieper, I., Stertmann, J., et al. In vitro toxicological characterisation of the S-containing arsenic metabolites thio-dimethylarsinic acid and dimethylarsinic glutathione. Toxicology 305 (2013), 109–119.
54. Lewars, E.G., Computational Chemistry: Introduction to the Theory and Applications of Molecular and Quantum Mechanics. 2003, Kluwer Academic Publishers.
55. Liu, J.-X., Zhou, G.-B., Chen, S.-J., Chen, Z., Arsenic compounds: revived ancient remedies in the fight against human malignancies. Curr. Opin. Chem. Biol. 16 (2012), 92–98.
56. Lloyd, N.C., Morgan, H.W., Nicholson, B.K., Ronimus, R.S., The composition of Ehrlich's Salvarsan: resolution of a century-old debate. Angew. Chem. Int. Ed. 44 (2005), 941–944.
57. Loffredo, C.A., Aposhian, H.V., Cebrian, M.E., Yamauchi, H., Silbergeld, E.K., Variability in human metabolism of arsenic. Environ. Res. 92 (2003), 85–91.
58. Lundberg, M., Siegbahn, P.E., Optimized spin crossings and transition states for short-range electron transfer in transition metal dimers. J. Phys. Chem. B 109 (2005), 10513–10520.
59. Mandal, B.K., Suzuki, K.T., Arsenic round the world: a review. Talanta 58 (2002), 201–235.
60. Mandal, B.K., Ogra, Y., Suzuki, K.T., Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem. Res. Toxicol. 14 (2001), 371–378.
61. Mandal, B.K., Ogra, Y., Anzai, K., Suzuki, K.T., Speciation of arsenic in biological samples. Toxicol. Appl. Pharmacol. 198 (2004), 307–318.
62. Mandal, B.K., Suzuki, K.T., Anzai, K., Yamaguchi, K., Sei, Y., A SEC–HPLC–ICP MS hyphenated technique for identification of sulfur-containing arsenic metabolites in biological samples. J. Chromatogr. B 874 (2008), 64–76.
63. Marchiset-Ferlay, N., Savanovitch, C., Sauvant-Rochat, M.-P., What is the best biomarker to assess arsenic exposure via drinking water?. Environ. Int. 39 (2012), 150–171.
64. Matulis, S.M., Morales, A.A., Yehiayan, L., Croutch, C., Gutman, D., Cai, Y., et al. Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line. Mol. Cancer Ther. 8 (2009), 1197–1206.
65. McKnight-Whitford, A., Le, X.C., Electrospray Mass Spectrometry of Arsenic Compounds and Thiol–Arsenic Complexes, Encyclopedia of Analytical Chemistry. 2006, John Wiley & Sons, Ltd.
66. Moreda-Piñeiro, J., Alonso-Rodríguez, E., Moreda-Piñeiro, A., Moscoso-Pérez, C., Muniategui-Lorenzo, S., López-Mahía, P., et al. Simultaneous pressurized enzymatic hydrolysis extraction and clean up for arsenic speciation in seafood samples before high performance liquid chromatography–inductively coupled plasma-mass spectrometry determination. Anal. Chim. Acta 679 (2010), 63–73.
67. Nakamuro, K., Sayato, Y., Comparative studies of chromosomal aberration induced by trivalent and pentavalent arsenic. Mutat. Res. Genet. Toxicol. 88 (1981), 73–80.
68. Naranmandura, H., Suzuki, K.T., Formation of dimethylthioarsenicals in red blood cells. Toxicol. Appl. Pharmacol. 227 (2008), 390–399.
69. Naranmandura, H., Suzuki, N., Suzuki, K.T., Trivalent arsenicals are bound to proteins during reductive methylation. Chem. Res. Toxicol. 19 (2006), 1010–1018.
70. Naranmandura, H., Ibata, K., Suzuki, K.T., Toxicity of dimethylmonothioarsinic acid toward human epidermoid carcinoma A431 cells. Chem. Res. Toxicol. 20 (2007), 1120–1125.
71. Naranmandura, H., Suzuki, N., Iwata, K., Hirano, S., Suzuki, T., Arsenic metabolism and thioarsenicals in hamsters and rats. Chem. Res. Toxicol. 20 (2007), 616–624.
72. Naranmandura, H., Suzuki, N., Suzuki, K.a.T., Reaction mechanism underlying the in vitro transformation of thioarsenicals. Toxicol. Appl. Pharmacol. 231 (2008), 328–335.
73. Naranmandura, H., Ogra, Y., Iwata, K., Lee, J., Suzuki, K.T., Weinfeld, M., et al. Evidence for toxicity differences between inorganic arsenite and thioarsenicals in human bladder cancer cells. Toxicol. Appl. Pharmacol. 238 (2009), 133–140.
74. Naranmandura, H., Bu, N., Suzuki, K.T., Lou, Y., Ogra, Y., Distribution and speciation of arsenic after intravenous administration of monomethylmonothioarsonic acid in rats. Chemosphere 81 (2010), 206–213.
75. Naranmandura, H., Carew, M.W., Xu, S., Lee, J., Leslie, E.M., Weinfeld, M., et al. Comparative toxicity of arsenic metabolites in human bladder cancer EJ-1 cells. Chem. Res. Toxicol. 24 (2011), 1586–1596.
76. Naranmandura, H., Rehman, K., Le, X.C., Thomas, D.J., Formation of methylated oxyarsenicals and thioarsenicals in wild-type and arsenic (+ 3 oxidation state) methyltransferase knockout mice exposed to arsenate. Anal. Bioanal. Chem. 405 (2013), 1885–1891.
77. Naujokas, M.F., Anderson, B., Ahsan, H., Aposhian, H.V., Graziano, J.H., Thompson, C., et al. The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem. Environ. Health Perspect. 121 (2013), 295–302.
78. Nearing, M.M., Koch, I., Reimer, K.J., Complementary arsenic speciation methods: a review. Spectrochim. Acta, Part B 99 (2014), 150–162.
79. Nicolis, I., Curis, E., Deschamps, P., Bénazeth, S., Arsenite medicinal use, metabolism, pharmacokinetics and monitoring in human hair. Biochimie 91 (2009), 1260–1267.
80. Ochi, T., Kita, K., Suzuki, T., Rumpler, A., Goessler, W., Francesconi, K.A., Cytotoxic, genotoxic and cell-cycle disruptive effects of thio-dimethylarsinate in cultured human cells and the role of glutathione. Toxicol. Appl. Pharmacol. 228 (2008), 59–67.
81. Orthaber, A., Sax, A.F., Francesconi, K.A., Oxygen versus sulfur: structure and reactivity of substituted arsine oxides and arsine sulfides. J. Comput. Chem. 33 (2012), 112–117.
82. Park, S.-G., Butcher, D.J., Investigation of the interaction between arsenic species and thiols via electrospray ionization tandem mass spectrometry. Microchem. J. 95 (2010), 57–66.
83. Pearson, R.G., Hard and soft acids and bases. J. Am. Chem. Soc. 85 (1963), 3533–3539.
84. Pinyayev, T.S., Kohan, M.J., Herbin-Davis, K., Creed, J.T., Thomas, D.J., Preabsorptive metabolism of sodium arsenate by anaerobic microbiota of mouse cecum forms a variety of methylated and thiolated arsenicals. Chem. Res. Toxicol. 24 (2011), 475–477.
85. Planer-Friedrich, B., Wallschläger, D., A critical investigation of hydride generation-based arsenic speciation in sulfidic waters. Environ. Sci. Technol. 43 (2009), 5007–5013.
86. Planer-Friedrich, B., Lehr, C., Matschullat, J., Merkel, B.J., Nordstrom, D.K., Sandstrom, M.W., Speciation of volatile arsenic at geothermal features in Yellowstone National Park. Geochim. Cosmochim. Acta 70 (2006), 2480–2491.
87. Planer-Friedrich, B., London, J., McCleskey, R.B., Nordstrom, D.K., Wallschläger, D., Thioarsenates in geothermal waters of Yellowstone National Park: determination, preservation, and geochemical importance. Environ. Sci. Technol. 41 (2007), 5245–5251.
88. Ponomarenko, O., Gherase, M.R., LeBlanc, M.S., Kim, C.-Y., Desouza, E.D., Farquharson, M.J., et al. Synchrotron X-ray absorption spectroscopy analysis of arsenic chemical speciation in human nail clippings. Environ. Chem. 11 (2014), 632–643.
89. Quick, A.J., Adams, R., Aliphatic arsonic and arsinic acids, and aliphatic-aromatic arsinic acids. J. Am. Chem. Soc. 44 (1922), 805–816.
90. Raab, A., Hansen, H.R., Zhuang, L., Feldmann, J., Arsenic accumulation and speciation analysis in wool from sheep exposed to arsenosugars. Talanta 58 (2002), 67–76.
91. Raab, A., Meharg, A.A., Jaspars, M., Genney, D.R., Feldmann, J., Arsenic–glutathione complexes—their stability in solution and during separation by different HPLC modes. J. Anal. At. Spectrom. 19 (2004), 183–190.
92. Raab, A., Wright, S.H., Jaspars, M., Meharg, A.A., Feldmann, J., Pentavalent arsenic can bind to biomolecules. Angew. Chem. Int. Ed. 46 (2007), 2594–2597.
93. Raml, R., Goessler, W., Traar, P., Ochi, T., Francesconi, K.A., Novel thioarsenic metabolites in human urine after ingestion of an arsenosugar, 2′,3′-dihydroxypropyl 5-deoxy-5-dimethylarsinoyl-β-d-riboside. Chem. Res. Toxicol. 18 (2005), 1444–1450.
94. Raml, R., Goessler, W., Francesconi, K.A., Improved chromatographic separation of thio-arsenic compounds by reversed-phase high performance liquid chromatography–inductively coupled plasma mass spectrometry. J. Chromatogr. A 1128 (2006), 164–170.
95. Raml, R., Rumpler, A., Goessler, W., Vahter, M., Li, L., Ochi, T., et al. Thio-dimethylarsinate is a common metabolite in urine samples from arsenic-exposed women in Bangladesh. Toxicol. Appl. Pharmacol. 222 (2007), 374–380.
96. Raml, R., Raber, G., Rumpler, A., Bauernhofer, T., Goessler, W., Francesconi, K.A., Individual variability in the human metabolism of an arsenic-containing carbohydrate, 2′,3′-dihydroxypropyl 5-deoxy-5-dimethylarsinoyl-β-d-riboside, a naturally occurring arsenical in seafood. Chem. Res. Toxicol. 22 (2009), 1534–1540.
97. Rehman, K., Naranmandura, H., Arsenic metabolism and thioarsenicals. Metallomics 4 (2012), 881–892.
98. Rossman, T.G., Mechanism of arsenic carcinogenesis: an integrated approach. Mutat. Res. Fundam. Mol. Mech. Mutagen. 533 (2003), 37–65.
99. Rubin, S.S.D., Alava, P., Zekker, I., Du Laing, G., Van de Wiele, T., Arsenic thiolation and the role of sulfate-reducing bacteria from the human intestinal tract. Environ. Health Perspect., 122, 2014, 817.
100. Saint-Jacques, N., Parker, L., Brown, P., Dummer, T., Arsenic in drinking water and urinary tract cancers: a systematic review of 30 years of epidemiological evidence. Environ. Health, 13, 2014, 44.
101. Sanz, E., Muñoz-Olivas, R., Cámara, C., Kumar, M., Ahamed, S., Arsenic speciation in rice, straw, soil, hair and nails samples from the arsenic-affected areas of Middle and Lower Ganga plain. J. Environ. Sci. Health Part A 42 (2007), 1695–1705.
102. Schwerdtle, T., Walter, I., Mackiw, I., Hartwig, A., Induction of oxidative DNA damage by arsenite and its trivalent and pentavalent methylated metabolites in cultured human cells and isolated DNA. Carcinogenesis 24 (2003), 967–974.
103. Shen, S., Li, X.F., Cullen, W.R., Weinfeld, M., Le, X.C., Arsenic binding to proteins. Chem. Rev. 113 (2013), 7769–7792.
104. Shimoda, Y., Kurosawa, H., Kato, K., Endo, Y., Yamanaka, K., Endo, G., Proposal for novel metabolic pathway of highly toxic dimethylated arsenics accompanied by enzymatic sulfuration, desulfuration and oxidation. J. Trace Elem. Med. Biol. 30 (2015), 129–136.
105. Siegbahn, P.E.M., The performance of hybrid DFT for mechanisms involving transition metal complexes in enzymes. J. Biol. Inorg. Chem. 11 (2006), 695–701.
106. Šlejkovec, Z., Falnoga, I., Goessler, W., van Elteren, J.T., Raml, R., Podgornik, H., et al. Analytical artefacts in the speciation of arsenic in clinical samples. Anal. Chim. Acta 607 (2008), 83–91.
107. Slotnick, M.J., Nriagu, J.O., Validity of human nails as a biomarker of arsenic and selenium exposure: a review. Environ. Res. 102 (2006), 125–139.
108. Stauder, S., Raue, B., Sacher, F., Thioarsenates in sulfidic waters. Environ. Sci. Technol. 39 (2005), 5933–5939.
109. Stice, S.A., Speciation, Metabolism, Toxicity, and Protein-binding of Different Arsenic Species in Human Cells. 2014, Florida International University, Miami, FL, USA.
110. Stice, S., Liu, G., Matulis, S., Boise, L.H., Cai, Y., Determination of multiple human arsenic metabolites employing high performance liquid chromatography inductively coupled plasma mass spectrometry. J. Chromatogr. B 1009-1010 (2016), 55–65.
111. Styblo, M., Thomas, D.J., Binding of arsenicals to proteins in anin vitromethylation system. Toxicol. Appl. Pharmacol. 147 (1997), 1–8.
112. Styblo, M., Del Razo, L.M., Vega, L., Germolec, D.R., LeCluyse, E.L., Hamilton, G.A., et al. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 74 (2000), 289–299.
113. Suess, E., Scheinost, A.C., Bostick, B.C., Merkel, B.J., Wallschlaeger, D., Planer-Friedrich, B., Discrimination of thioarsenites and thioarsenates by X-ray absorption spectroscopy. Anal. Chem. 81 (2009), 8318–8326.
114. Suess, E., Wallschläger, D., Planer-Friedrich, B., Stabilization of thioarsenates in iron-rich waters. Chemosphere 83 (2011), 1524–1531.
115. Suess, E., Mehlhorn, J., Planer-Friedrich, B., Anoxic, ethanolic, and cool — an improved method for thioarsenate preservation in iron-rich waters. Appl. Geochem. 62 (2015), 224–233.
116. Suzuki, K.T., Katagiri, A., Sakuma, Y., Ogra, Y., Ohmichi, M., Distributions and chemical forms of arsenic after intravenous administration of dimethylarsinic and monomethylarsonic acids to rats. Toxicol. Appl. Pharmacol. 198 (2004), 336–344.
117. Suzuki, K.T., Mandal, B.K., Katagiri, A., Sakuma, Y., Kawakami, A., Ogra, Y., et al. Dimethylthioarsenicals as arsenic metabolites and their chemical preparations. Chem. Res. Toxicol. 17 (2004), 914–921.
118. Suzuki, K.T., Iwata, K., Naranmandura, H., Suzuki, N., Metabolic differences between two dimethylthioarsenicals in rats. Toxicol. Appl. Pharmacol. 218 (2007), 166–173.
119. Suzuki, N., Naranmandura, H., Hirano, S., Suzuki, K.T., Theoretical calculations and reaction analysis on the interaction of pentavalent thioarsenicals with biorelevant thiol compounds. Chem. Res. Toxicol. 21 (2008), 550–553.
120. Suzuki, S., Arnold, L.L., Pennington, K.L., Chen, B., Naranmandura, H., Le, X.C., et al. Dietary administration of sodium arsenite to rats: relations between dose and urinary concentrations of methylated and thio-metabolites and effects on the rat urinary bladder epithelium. Toxicol. Appl. Pharmacol. 244 (2010), 99–105.
121. Teixeira, M.C., Ciminelli, V.S.T., Dantas, M.S.S., Diniz, S.F., Duarte, H.A., Raman spectroscopy and DFT calculations of As(III) complexation with a cysteine-rich biomaterial. J. Colloid Interface Sci. 315 (2007), 128–134.
122. Thomas, D.J., Bradham, K., Role of complex organic arsenicals in food in aggregate exposure to arsenic. J. Environ. Sci. 49 (2016), 86–96.
123. Tossell, J.A., Zimmermann, M.D., Calculation of the structures, stabilities, and vibrational spectra of arsenites, thioarsenites and thioarsenates in aqueous solution. Geochim. Cosmochim. Acta 72 (2008), 5232–5242.
124. Toulouze, M., Pilme, J., Pauzat, F., Ellinger, Y., Arsenic in prebiotic species: a theoretical approach. PCCP 14 (2012), 10515–10522.
125. Tsimberidou, A.M., Camacho, L.H., Verstovsek, S., Ng, C., Hong, D.S., Uehara, C.K., et al. A phase I clinical trial of darinaparsin in patients with refractory solid tumors. Clin. Cancer Res. 15 (2009), 4769–4776.
126. Valenzuela, O.L., Borja-Aburto, V.H., Garcia-Vargas, G.G., Cruz-Gonzalez, M.B., Garcia-Montalvo, E.A., Calderon-Aranda, E.S., et al. Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic. Environ. Health Perspect. 113 (2005), 250–254.
127. Van de Wiele, T., Gallawa, C.M., Kubachka, K.M., Creed, J.T., Basta, N., Dayton, E.A., et al. Arsenic metabolism by human gut microbiota upon in vitro digestion of contaminated soils. Environ. Health Perspect., 2010, 1004–1009.
128. Vela, N.P., Heitkemper, D.T., Stewart, K.R., Arsenic extraction and speciation in carrots using accelerated solvent extraction, liquid chromatography and plasma mass spectrometry. Analyst 126 (2001), 1011–1017.
129. Wallschläger, D., Stadey, C.J., Determination of (oxy) thioarsenates in sulfidic waters. Anal. Chem. 79 (2007), 3873–3880.
130. Wang, Z.-Y., Chen, Z., Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 111 (2008), 2505–2515.
131. Wang, P., Sun, G., Jia, Y., Meharg, A.A., Zhu, Y., A review on completing arsenic biogeochemical cycle: microbial volatilization of arsines in environment. J. Environ. Sci. 26 (2014), 371–381.
132. Wang, W., Cheng, S., Zhang, D., Association of inorganic arsenic exposure with liver cancer mortality: a meta-analysis. Environ. Res. 135 (2014), 120–125.
133. Wang, D., Shimoda, Y., Kurosawa, H., Liu, J., Xu, X., Liu, X., et al. Excretion patterns of arsenic and its metabolites in human saliva and urine after ingestion of Chinese seaweed. Int. J. Environ. Anal. Chem. 95 (2015), 379–389.
134. Wang, Q.Q., Thomas, D.J., Naranmandura, H., Importance of being thiomethylated: formation, fate, and effects of methylated thioarsenicals. Chem. Res. Toxicol. 28 (2015), 281–289.
135. Waxman, S., Anderson, K.C., History of the development of arsenic derivatives in cancer therapy. Oncologist 6 (2001), 3–10.
136. Wilkin, R.T., Wallschläger, D., Ford, R.G., Speciation of arsenic in sulfidic waters. Geochem. Trans. 4 (2003), 1–7.
137. Wood, S.A., Tait, C.D., Janecky, D.R., A Raman spectroscopic study of arsenite and thioarsenite species in aqueous solution at 25 °C. Geochem. Trans., 3, 2002, 1.
138. Wu, J., Henderson, C., Feun, L., Van Veldhuizen, P., Gold, P., Zheng, H., et al. Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma. Invest. New Drugs 28 (2010), 670–676.
139. Xiao, F., Wang, S., Xu, L., Wang, Y., Yuan, Z., Jia, Y., Adsorption of monothioarsenate on amorphous aluminum hydroxide under anaerobic conditions. Chem. Geol. 407-408 (2015), 46–53.
140. Xie, R., Johnson, W., Spayd, S., Hall, G.S., Buckley, B., Arsenic speciation analysis of human urine using ion exchange chromatography coupled to inductively coupled plasma mass spectrometry. Anal. Chim. Acta 578 (2006), 186–194.
141. Xu, X., Truhlar, D.G., Accuracy of effective core potentials and basis sets for density functional calculations, including relativistic effects, as illustrated by calculations on arsenic compounds. J. Chem. Theory Comput. 7 (2011), 2766–2779.
142. Yehiayan, L., Pattabiraman, M., Kavallieratos, K., Wang, X., Boise, L.H., Cai, Y., Speciation, formation, stability and analytical challenges of human arsenic metabolites. J. Anal. At. Spectrom. 24 (2009), 1397–1405.
143. Yehiayan, L., Membreno, N., Matulis, S., Boise, L.H., Cai, Y., Extraction tool and matrix effects on arsenic speciation analysis in cell lines. Anal. Chim. Acta 699 (2011), 187–192.
144. Yehiayan, L., Stice, S., Liu, G., Matulis, S., Boise, L.H., Cai, Y., Dimethylarsinothioyl glutathione as a metabolite in human multiple myeloma cell lines upon exposure to darinaparsin. Chem. Res. Toxicol. 27 (2014), 754–764.
145. Zampella, G., Neupane, K.P., De Gioia, L., Pecoraro, V.L., The importance of stereochemically active lone pairs for influencing PbII and AsIII protein binding. Chem. Eur. J. 18 (2012), 2040–2050.
146. Zhang, W., Hu, Y., Cheng, H., Optimization of microwave-assisted extraction for six inorganic and organic arsenic species in chicken tissues using response surface methodology. J. Sep. Sci. 38 (2015), 3063–3070.
147. Zhou, G.-B., Zhao, W.-L., Wang, Z.-Y., Chen, S.-J., Chen, Z., Retinoic acid and arsenic for treating acute promyelocytic leukemia. PLoS Med., 2, 2005, e12.